![](/img/cover-not-exists.png)
3502 ORAL Final results of a randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP)
S.E. Al-Batran, J.T. Hartmann, S. Probst, R. Hofheinz, J. Stoehlmacher, C. Pauligk, S. Hollerbach, G. Schuch, N. Homann, E. JägerVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)71005-4
File:
PDF, 76 KB
english, 2007